The NYU and Johns Hopkins University study participants were given one large dose of psilocybin in a capsule. Then they were guided through the experience by a psychotherapist. They noticed an immediate reduction in the depression and anxiety caused by terminal cancer.
80% of the participants reported moderately or greatly improved well-being or life satisfaction. Many experienced the "oneness" with the universe that other psychedelic explorers have written about.
Psilocybin, once part of the psychiatric pharmacopeia, was made a schedule 1 drug in the US, severely limiting its research and potential uses as an anti-depressant or spiritually uplifting experience.
The volunteers had “profoundly meaningful and spiritual experiences” which made most of them rethink life and death, ended their despair and brought about lasting improvement in the quality of their lives.
Source: The Guardian
Click here to view the article